267 related articles for article (PubMed ID: 6127132)
21. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
Zimmer R
Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
[TBL] [Abstract][Full Text] [Related]
22. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
Palfreyman MG; McDonald IA; Bey P; Schechter PJ; Sjoerdsma A
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):967-87. PubMed ID: 3266532
[TBL] [Abstract][Full Text] [Related]
23. Altered alpha-adrenergic responses of vas deferens to noradrenaline and tyramine from rats with short- and long-term alloxan diabetes.
Oztürk Y; Yildizoğlu-Ari N; Altan VM
Gen Pharmacol; 1994 Nov; 25(7):1519-24. PubMed ID: 7896069
[TBL] [Abstract][Full Text] [Related]
24. The effect of various monoamine oxidase (MAO) inhibitors on the response of blood pressure of rats and cats to tyramine.
Abdo-Rubo A
Acta Physiol Hung; 1990; 75(4):321-36. PubMed ID: 2127505
[TBL] [Abstract][Full Text] [Related]
25. Functional characterisation of alpha(1)-adrenoceptors in denervated rat vas deferens.
Campos M; de Lucena Morais P; Pupo AS
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jul; 368(1):72-8. PubMed ID: 12845422
[TBL] [Abstract][Full Text] [Related]
26. The serotonin paradox: drug-receptor interaction in rat vas deferens.
Jurkiewicz A; do Carmo LG; Yomura MH; Jurkiewicz NH
Acta Physiol Pharmacol Ther Latinoam; 1999; 49(4):210-4. PubMed ID: 10797863
[TBL] [Abstract][Full Text] [Related]
27. The neuropharmacological profile of N-methyl-N-propargyl-2-aminotetralin: a potent monoamine oxidase inhibitor.
Hazelhoff B; De Vries JB; Dijkstra D; de Jong W; Horn AS
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):50-8. PubMed ID: 2413370
[TBL] [Abstract][Full Text] [Related]
28. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
Kerecsen L; Bunag RD
J Pharmacol Exp Ther; 1989 Nov; 251(2):645-9. PubMed ID: 2509682
[TBL] [Abstract][Full Text] [Related]
29. Desensitization by noradrenaline of responses to stimulation of pre- and postsynaptic adrenoceptors.
Ball N; Danks JL; Dorudi S; Nasmyth PA
Br J Pharmacol; 1982 May; 76(1):201-10. PubMed ID: 7082904
[TBL] [Abstract][Full Text] [Related]
30. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
Doxey JC; Roach AG; Smith CF
Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
[TBL] [Abstract][Full Text] [Related]
31. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
Severina IS
Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
[TBL] [Abstract][Full Text] [Related]
32. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
Dénes B; Greeff K; Tawfik H
Arzneimittelforschung; 1982; 32(3):201-7. PubMed ID: 6805481
[TBL] [Abstract][Full Text] [Related]
33. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
Andreeva NI; Golovina SM; Faermark MF; Shvarts GIa; Mashkovskiĭ MD
Farmakol Toksikol; 1991; 54(2):38-40. PubMed ID: 1884793
[TBL] [Abstract][Full Text] [Related]
34. Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction.
Pickar D; Cohen RM; Jimerson DC; Lake CR; Murphy DL
Psychopharmacology (Berl); 1981; 74(1):8-12. PubMed ID: 6791210
[TBL] [Abstract][Full Text] [Related]
35. Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat.
Ask AL; Hellström W; Norrman S; Ogren SO; Ross SB
Neuropharmacology; 1982 Apr; 21(4):299-308. PubMed ID: 7088264
[TBL] [Abstract][Full Text] [Related]
36. Modification of alpha-2 presynaptic receptor activity and catecholamine release following chronic MAO inhibition.
Finberg JP; Ari G; Lavian G; Hovevey-Sion D
J Neural Transm Suppl; 1990; 32():405-12. PubMed ID: 1965197
[TBL] [Abstract][Full Text] [Related]
37. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
Ohmura T; Oshita M; Kigoshi S; Muramatsu I
Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
[TBL] [Abstract][Full Text] [Related]
38. The effect of cocaine and imipramine on tyramine-induced release of noradrenaline-3H from the rat vas deferens in vitro.
Barnett A; Staub M; Symchowicz S
Br J Pharmacol; 1969 May; 36(1):79-84. PubMed ID: 5768130
[TBL] [Abstract][Full Text] [Related]
39. Fasting reduces the responses of the rat vas deferens to sympathomimetics.
Tayo FM
Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):249-57. PubMed ID: 6712358
[TBL] [Abstract][Full Text] [Related]
40. Reversible, amine--selective effects of acute and chronic brofaromine treatment in the rat.
Dyck LE; Boulton AA
Life Sci; 1992; 51(1):59-66. PubMed ID: 1614274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
